Ebola outbreak expands in DRC as cases reach Uganda
- An ongoing Ebola virus outbreak in the Democratic Republic of the Congo has expanded to affect at least nine health zones, prompting an international public health emergency declaration.
- Health officials noted that four types of Ebola virus cause illness in humans, and genomic analysis confirms that this specific event is driven by the Bundibugyo virus subtype.
- In response to the spread, the Centers for Disease Control and Prevention activated its Emergency Response Center.
An ongoing Ebola virus outbreak in the Democratic Republic of the Congo has expanded to affect at least nine health zones, prompting an international public health emergency declaration. Capt. Satish K. Pillai, incident manager for the Centers for Disease Control and Prevention Ebola response, announced that two confirmed cases have also been identified in Uganda in individuals who traveled there from the Democratic Republic of the Congo.
World Health Organization Declares International Emergency
Health officials noted that four types of Ebola virus cause illness in humans, and genomic analysis confirms that this specific event is driven by the Bundibugyo virus subtype. According to Capt. Satish K. Pillai, the current event marks the 18th recorded Ebola outbreak in the Democratic Republic of the Congo since the virus was first identified in 1976. Previous outbreaks caused by the Bundibugyo species remain rare, with prior incidents documented in Uganda in 2007 and in the Democratic Republic of the Congo in 2015. The country’s prior Ebola outbreak concluded in December 2025.
Federal Response and Containment Measures
In response to the spread, the Centers for Disease Control and Prevention activated its Emergency Response Center. Agency personnel embedded within country offices in the Democratic Republic of the Congo and Uganda are currently providing on-the-ground support. Their work encompasses surveillance, contact tracing, laboratory testing, infection prevention and control, border health activities, and community engagement, alongside added logistical mobilization from headquarters in Atlanta. Medical authorities emphasize that no Food and Drug Administration-approved vaccines or therapeutics currently exist for the Bundibugyo Ebola subtype. Consequently, proactive supportive care—including fluid and electrolyte management alongside complication treatments—remains the primary clinical strategy for optimizing patient outcomes.
Risk Assessment for Domestic Travelers
Federal health agencies maintain that the immediate public health risk to the United States remains low. Officials advise individuals traveling to the affected region to avoid contact with symptomatic individuals, monitor for sudden illness, report potential symptoms immediately, and adhere strictly to published travel health guidance.